BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Continuous Glucose Monitoring (CGM) Market Will Reach $568.5 Million Globally By 2020 - Allied Market Research


12/23/2013 12:03:33 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

December 23, 2013 -- According to the new market research report titled "Continuous Glucose Monitoring Market (CGM Systems, Application, Diabetic Type, and Adoption by Age Group) - Current Trends, Size, Share, Industry Analysis, Competitive Intelligence, Growth, Opportunities and Global Forecasts, 2012 - 2020" by Allied Market Research, the global continuous glucose monitoring (CGM) market is projected to reach $568.5 million by 2020 from 2012 value of $194.8 million growing at a CAGR of 14.8% during 2013 - 2020. The major factors driving the market growth are convenience offered by CGM over conventional glucose monitoring devices, earlier detection of the hypo and hyperglycemic events, rise in incidences of diabetes cases globally, and awareness among global population.

The complete report is available at http://www.alliedmarketresearch.com/continuous-glucose-monitoring-cgm-market=88

"The market is overcoming several challenges towards the commercialization of closed loop CGMs with significant focus on technological innovation. This is expected to take the concept of CGM to a next level from research to mass adoption" noted AMR analyst Debbie Shields. Despite such encouraging innovations, commercialization has not reached to desired levels. Major factors responsible for this are issues related with accuracy as well as cost, less attractive reimbursement coverage, and strict regulatory impositions. "However, the under commercialization is presenting opportunities for the marketers as new and innovative products will easily take the advantage of lower product presence" Debbie explains. The impact of FDA approval for artificial pancreas, superiority of CGMs over self-monitoring devices and rise in diabetes cases will have significant impact on the overall market growth.

The market is categorized into CGM devices, application, type of diabetes, and on the basis of age. In the CGM application market, home settings was largest revenue generating segment in 2012. CGM application in hospitals is expected to emerge to be the most attractive segment in the overall application market during the forecast period. In the overall market, largest revenue is projected to be generated from glucose sensors. This is mainly due to the fact that more improvement is expected in the sensors during forecast period.

Transmitters and receivers market accounted for the largest share of revenue of the overall Global continuous glucose monitoring systems market at $88.5 million in 2012. However, Glucose sensors market will surpass transmitters & receivers and attain a market size of $235.9 million by 2020 growing at a CAGR of 15.3% during 2013-2020. Insulin pumps segment is expected to have the highest growth rate during the analysis period.

North America region accounted for the largest share of revenue of the overall global continuous glucose monitoring systems market in 2012, whereas Asia Pacific will have the highest growth rate during the analysis period.

The report analyzes 2011, 2012 market and forecast demand for continuous glucose monitors through 2020. Companies profiled in this report include Medtronic Inc., Dexcom Inc., Novo Nordisk, Spring Health Solution Ltd, Roche, Animas Corporation, Ypsomed AG, and Insulet Corporation.

About Us:

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based inPortland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in capturing most accurate market data and confirms utmost accuracy of our market forecasts. Each and every data presented in the reports published by us is also extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

Sona Padman

5320 SW Macadam Avenue,

Suite 100, Portland, OR 97239

United States

Direct: +1(617)674-4143

Toll Free: +1(855)711-1555 (U.S. & Canada)

Fax: +1(855)550-5975

Email: sales@alliedmarketresearch.com

Web: http://www.alliedmarketresearch.com

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES